SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $293,000 | -14.3% | 6,602 | +9.6% | 0.01% | -25.0% |
| Q2 2021 | $342,000 | +2.1% | 6,026 | +34.5% | 0.01% | +14.3% |
| Q1 2021 | $335,000 | -16.9% | 4,481 | -3.9% | 0.01% | -12.5% |
| Q4 2020 | $403,000 | +30.8% | 4,663 | -7.5% | 0.01% | 0.0% |
| Q3 2020 | $308,000 | +48.8% | 5,042 | +1.1% | 0.01% | +33.3% |
| Q2 2020 | $207,000 | -31.2% | 4,986 | -50.1% | 0.01% | -73.9% |
| Q2 2016 | $301,000 | -60.0% | 10,000 | -33.3% | 0.02% | -30.3% |
| Q1 2015 | $753,000 | – | 15,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |